MiMedx Group, Inc. reported preliminary revenue results for the fourth quarter and full year ended December 31, 2017. For the fourth quarter, the company recorded record revenue of $90.9 million, a $21.0 million or 30% increase over 2016 fourth quarter revenue of $69.9 million.

For the year, the company recorded revenue of $324.5 million, a $79.5 million or 32% increase over 2016 revenue of $245.0 million.

The company reiterated earnings guidance for the first quarter and full year of 2018. For the quarter, the company revenue forecasted to be in the range of $90.5 million to $92.0 million.

For the full year 2018, the company's revenue estimated between $383 million to $387 million, gross profit margins expected to be in the range of 89% to 90%, operating income expected to be in the range of 15% to 17%, GAAP diluted EPS projected to be in the range of $0.30 to $0.35 and adjusted diluted EPS projected to be in the range of $0.45 to $0.50.